NON STANDARDIZED ALLERGENIC EXTRACTS - NON POLLENS Strength
Active ingredient(s) See footnote 8 : Strength NON POLLEN : 40000 UNIT / ML · DIN 02372428 · GREER LABORATORIES INC 639 Nuway Circle Ne Lenoir North Carolina United States 28645
Health Canada status: MARKETED
What is NON STANDARDIZED ALLERGENIC EXTRACTS - NON POLLENS?
NON STANDARDIZED ALLERGENIC EXTRACTS - NON POLLENS Strength contains Active ingredient(s) See footnote 8 : Strength NON POLLEN : 40000 UNIT / ML. It is listed in the Health Canada Drug Product Database under DIN 02372428, held by GREER LABORATORIES INC 639 Nuway Circle Ne Lenoir North Carolina United States 28645, supplied as Liquid for Subcutaneous , Intradermal administration. Health Canada currently lists it as marketed, status dated 29-Aug-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is NON STANDARDIZED ALLERGENIC EXTRACTS - NON POLLENS used for?
Allergenic Extracts are indicated for the diagnosis and treatment of patients with immediate hypersensitivity allergy to the respective allergens, inhaled, ingested or otherwise introduced into contact with sensitive tissues. Immunotherapy with Allergenic Extracts is indicated when testing and patient history have identified the offending allergens and when it is not possible or practical to avoid these allergens.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02372428 |
|---|---|
| Brand name | NON STANDARDIZED ALLERGENIC EXTRACTS - NON POLLENS |
| Generic / active ingredient | Active ingredient(s) See footnote 8 : Strength NON POLLEN : 40000 UNIT / ML |
| Manufacturer | GREER LABORATORIES INC 639 Nuway Circle Ne Lenoir North Carolina United States 28645 |
| Strength | Strength |
| Dosage form | Liquid |
| Route of administration | Subcutaneous , Intradermal |
| Schedule | SCHEDULE D |
| ATC code | V01AA20 VARIOUS |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 29-Aug-2012 |
| Original market date | 2012-08-29 |
How is it administered?
Subcutaneous injection for immunotherapy; scratch, prick-puncture, or intradermal for diagnosis. Dosage is individualized based on skin test reactivity and patient tolerance.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
2-8°C
How is it supplied?
5, 10, 30 and 50 mL in aqueous or 50% glycerin buffered saline; dropper vials
Contraindications
No absolute contraindications. Avoid in individuals without skin test/clinical sensitivity, bleeding diathesis, or autoimmune disease. Children with nephrotic syndrome require careful consideration.
Warnings and precautions
Risk of severe or fatal anaphylaxis. Must be administered by physicians experienced in anaphylaxis management. Observe patients for 20 minutes. Not for intravenous use.
What can be used instead?
Other Canadian products sharing ATC code V01AA20 VARIOUS. 12 of 26 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALLERGENIC EXTRACT - NON-POLLENS | 500 UNIT | SOLUTION | JUBILANT HOLLISTERSTIER LLC | MARKETED | DIN 02226944 |
| ALLERGENIC EXTRACT - POLLENS | 40000 UNIT | SOLUTION | JUBILANT HOLLISTERSTIER LLC | MARKETED | DIN 02226928 |
| ALLERGENIC EXTRACT NON POLLENS | 100000 UNIT | LIQUID | ALK-ABELLO INC | MARKETED | DIN 00299979 |
| ALLERGENIC EXTRACT POLLENS | 100000 UNIT | LIQUID | ALK-ABELLO INC | MARKETED | DIN 00299987 |
| NON STANDARDIZED ALLERGENIC EXTRACTS - POLLENS | 40000 UNIT | LIQUID | GREER LABORATORIES INC | MARKETED | DIN 02372444 |
| OMEGA ALLERGENIC EXTRACTS - NON-POLLENS (AQUEOUS) | 40000 UNIT | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02247756 |
| OMEGA ALLERGENIC EXTRACTS - NON-POLLENS (GLYCERINATED) | 40000 UNIT | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02247757 |
| OMEGA ALLERGENIC EXTRACTS - NON-POLLENS (SUSPAL) | 40000 UNIT | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02247758 |
| OMEGA ALLERGENIC EXTRACTS - POLLENS (AQUEOUS) | 40000 UNIT | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02247753 |
| OMEGA ALLERGENIC EXTRACTS - POLLENS (GLYCERINATED) | 40000 UNIT | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02247754 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for NON STANDARDIZED ALLERGENIC EXTRACTS - NON POLLENS
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.